List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 35 studies with search of: "Carcinosarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma
Condition: Uterine Carcinosarcoma
Intervention: Drug: Carboplatin, paclitaxel, BSI-201
2 Recruiting Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
Conditions: Mesenchymal Tumor;   Carcinosarcoma;   Leiomyosarcoma
Interventions: Drug: PegLiposomal Doxorubicin;   Drug: Carboplatin
3 Active, not recruiting Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma
Condition: Sarcoma
Intervention: Drug: imatinib mesylate
4 Active, not recruiting Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus
Condition: Sarcoma
Intervention: Drug: thalidomide
5 Active, not recruiting Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
Conditions: Advanced Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Ovarian Carcinosarcoma
Intervention: Drug: Avastin
6 Recruiting Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
Conditions: Cancer-Related Problem/Condition;   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: pegfilgrastim;   Drug: carboplatin;   Drug: paclitaxel;   Procedure: adjuvant therapy
7 Active, not recruiting Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
Condition: Sarcoma
Intervention: Drug: sorafenib tosylate
8 Active, not recruiting Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
Condition: Sarcoma
Interventions: Drug: carboplatin;   Drug: paclitaxel
9 Completed Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: topotecan hydrochloride
10 Active, not recruiting Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Condition: Sarcoma
Interventions: Drug: docetaxel;   Drug: gemcitabine hydrochloride
11 Completed Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: ifosfamide;   Drug: paclitaxel
12 Completed Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
Condition: Sarcoma
Interventions: Drug: cisplatin;   Drug: ifosfamide;   Procedure: adjuvant therapy;   Radiation: radiation therapy
13 Recruiting Pazopanib in Treating Patients With Metastatic Soft Tissue Sarcoma That Has Relapsed or Not Responded to Treatment
Conditions: Endometrial Cancer;   Kidney Cancer;   Metastatic Cancer;   Ovarian Cancer;   Peripheral Nervous System Neoplasm;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: pazopanib hydrochloride;   Other: placebo
14 Completed Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Conditions: Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma
Interventions: Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride
15 Recruiting VEGF Trap in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma
Interventions: Biological: aflibercept;   Other: immunoenzyme technique;   Other: pharmacological study
16 Completed Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Condition: Tumor
Interventions: Drug: belinostat;   Drug: 5-Fluorouracil (5-FU)
17 Active, not recruiting Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
Conditions: Ovarian Cancer;   Sarcoma
Intervention: Drug: sorafenib tosylate
18 Completed Thalidomide in Treating Patients With Gynecologic Sarcomas
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: thalidomide
19 Active, not recruiting Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Drug: temozolomide
20 Recruiting Sunitinib in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: sunitinib malate

Previous Page Studies Shown (1-20) Next Page (21-35)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services